On the occasion of the celebration of the 80th anniversary of the founding of the CHIESI Group, the pharmaceutical company CHIESI HELLAS SA organized an event at the Museum of Cycladic Art, within the context of the exhibition “IASIS: Health, Disease, Treatment from Homer to Galen” on 26.05.2015.
Invited were collaborators, representatives of the pharmaceutical industry, as well as representatives of the state and the media. The event was a great successful thanks to the tour by the Museum’s archaeologists, who impressed the attendees, unfolding the path of therapeutic and research methodology in Greece for 15 centuries “...from Homer to Galen”.
CHIESI HELLAS SA, Major Sponsor of the “IASIS” exhibition, supports at every opportunity the activities and actions that highlight the contribution of the Greek spirit to science, especially in the field of Health and Research, as stressed in the speech of the company’s CEO, Mr. Stavros G. Theodorakis.
The CHIESI Group, with research, major investments and awards, develops innovative products that complement and strengthen the arsenal of health scientists and provide reliable solutions to respiratory, cardiovascular, neonatal disorders as well as special and rare diseases. It is a pioneering research company and has recently received the first marketing authorization from the European Medicines Agency (EMA) for treatment of regenerative medicine, with autologous human stem cells.
At the Group’s headquarters in Parma Italy, a new state of the art research center was launched in 2011 and was soon awarded by the “International Society for Pharmaceutical Engineering” (IPSE) for its eco-friendly construction and research support for new innovative high-tech treatments.
It has 24 subsidiaries in Europe, America and Asia. The Greek subsidiary CHIESI HELLAS SA was founded in Athens in 1998. It has been expanding its resources and reinforcing local partnerships, and is today a well organized company, with a strong presence in the Greek pharmaceutical market and with high growth rates guaranteeing an even better future. As an expression of the Group’s vision, CHIESI HELLAS SA will continue to invest and support the scientific community and research.